| Preservation of the inner retina in retinitis pigmentosa: a morphometric analysis A Santos, MS Humayun, E de Juan, RJ Greenburg, MJ Marsh, IB Klock, ... Archives of ophthalmology 115 (4), 511-515, 1997 | 838 | 1997 |
| Interim results from the international trial of Second Sight's visual prosthesis MS Humayun, JD Dorn, L Da Cruz, G Dagnelie, JA Sahel, PE Stanga, ... Ophthalmology 119 (4), 779-788, 2012 | 828 | 2012 |
| The Argus II epiretinal prosthesis system allows letter and word reading and long-term function in patients with profound vision loss L Da Cruz, BF Coley, J Dorn, F Merlini, E Filley, P Christopher, FK Chen, ... British Journal of Ophthalmology 97 (5), 632-636, 2013 | 439 | 2013 |
| Five-year safety and performance results from the Argus II retinal prosthesis system clinical trial L da Cruz, JD Dorn, MS Humayun, G Dagnelie, J Handa, PO Barale, ... Ophthalmology 123 (10), 2248-2254, 2016 | 406 | 2016 |
| Blind subjects implanted with the Argus II retinal prosthesis are able to improve performance in a spatial-motor task AK Ahuja, JD Dorn, A Caspi, MJ McMahon, G Dagnelie, P Stanga, ... British Journal of Ophthalmology 95 (4), 539-543, 2011 | 389 | 2011 |
| Long-term results from an epiretinal prosthesis to restore sight to the blind AC Ho, MS Humayun, JD Dorn, L Da Cruz, G Dagnelie, J Handa, ... Ophthalmology 122 (8), 1547-1554, 2015 | 302 | 2015 |
| The detection of motion by blind subjects with the epiretinal 60-electrode (Argus II) retinal prosthesis JD Dorn, AK Ahuja, A Caspi, L Da Cruz, G Dagnelie, JA Sahel, ... JAMA ophthalmology 131 (2), 183-189, 2013 | 216 | 2013 |
| Pathophysiological molecular mechanisms of obesity: a link between MAFLD and NASH with cardiovascular diseases J Gutiérrez-Cuevas, A Santos, J Armendariz-Borunda International Journal of molecular sciences 22 (21), 11629, 2021 | 163 | 2021 |
| Factors affecting perceptual threshold in Argus II retinal prosthesis subjects AK Ahuja, J Yeoh, JD Dorn, A Caspi, V Wuyyuru, MJ McMahon, ... Translational vision science & technology 2 (4), 1-1, 2013 | 141 | 2013 |
| Preliminary 6 month results from the argustm ii epiretinal prosthesis feasibility study MS Humayun, JD Dorn, AK Ahuja, A Caspi, E Filley, G Dagnelie, ... 2009 Annual International Conference of the IEEE Engineering in Medicine and …, 2009 | 129 | 2009 |
| Roles of Nrf2 in liver diseases: molecular, pharmacological, and epigenetic aspects M Galicia-Moreno, S Lucano-Landeros, HC Monroy-Ramirez, ... Antioxidants 9 (10), 980, 2020 | 96 | 2020 |
| Implantable micropump for drug delivery in patients with diabetic macular edema M Humayun, A Santos, JC Altamirano, R Ribeiro, R Gonzalez, ... Translational vision science & technology 3 (6), 5-5, 2014 | 89 | 2014 |
| Twelve-month short-term safety and visual-acuity results from a multicentre prospective study of epiretinal strontium-90 brachytherapy with bevacizumab for the treatment of … MP Ávila, ME Farah, A Santos, JP Duprat, BW Woodward, J Nau British Journal of Ophthalmology 93 (3), 305-309, 2009 | 89 | 2009 |
| Molecular mechanisms of obesity-linked cardiac dysfunction: an up-date on current knowledge J Gutiérrez-Cuevas, A Sandoval-Rodriguez, A Meza-Rios, ... Cells 10 (3), 629, 2021 | 88 | 2021 |
| Use of the Argus II retinal prosthesis to improve visual guidance of fine hand movements MP Barry, G Dagnelie, Argus II Study Group Investigative ophthalmology & visual science 53 (9), 5095-5101, 2012 | 72 | 2012 |
| Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD MP Avila, ME Farah, A Santos, Z Kapran, JP Duprat, BW Woodward, ... Retina 29 (2), 157-169, 2009 | 72 | 2009 |
| Characterization and pharmacokinetics of triamcinolone acetonide-loaded liposomes topical formulations for vitreoretinal drug delivery JC Altamirano-Vallejo, J Navarro-Partida, A Gonzalez-De la Rosa, ... Journal of Ocular Pharmacology and Therapeutics 34 (5), 416-425, 2018 | 71 | 2018 |
| Polymeric implants for the treatment of intraocular eye diseases: trends in biodegradable and non-biodegradable materials P García-Estrada, MA García-Bon, EJ López-Naranjo, ... Pharmaceutics 13 (5), 701, 2021 | 65 | 2021 |
| Liver cancer: therapeutic challenges and the importance of experimental models M Galicia-Moreno, JA Silva-Gomez, S Lucano-Landeros, A Santos, ... Canadian Journal of Gastroenterology and Hepatology 2021 (1), 8837811, 2021 | 59 | 2021 |
| Therapies based on nanoparticles for eye drug delivery A Meza-Rios, J Navarro-Partida, J Armendariz-Borunda, A Santos Ophthalmology and Therapy 9 (3), 1-14, 2020 | 59 | 2020 |
